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Chagas disease is caused by the flagellate protozoan Trypanosoma cruzi, affecting
millions of people throughout Latin America. The parasite dampens host immune
response causing modifications in diverse lymphoid compartments, including the
thymus. T. cruzi trans-sialidase (TS) seems to play a fundamental role in such
immunopathological events. This unusual enzyme catalyses the transference of sialic
acid molecules from host glycoconjugates to acceptor molecules placed on the parasite
surface. TS activity mediates several biological effects leading to the subversion of host
immune system, hence favoring both parasite survival and the establishment of chronic
infection. This review summarizes current findings on the roles of TS in the immune
response during T. cruzi infection.
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INTRODUCTION
The protozoan parasite Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease.
During their life cycle, T. cruzi acquires different morphologies, alternating between an insect
vector and the vertebrate host (Tarleton et al., 2007; Ribeiro et al., 2012). Vector-borne transmission
occurs when infected bugs take a blood meal releasing simultaneously contaminated feces with
infective metacyclic trypomastigotes near the site of the mammal bite wound (Tyler and Engman,
2001). Once inside the host, parasites differentiate to bloodstream trypomastigotes, which can
infect host cells where they differentiate into intracellular amastigotes.
Besides vectorial transmission, other forms of infection exist, i.e., organ transplantation, blood
transfusion as well as vertical and oral transmission. Chagas disease progresses from an initial acute
phase characterized by a large number of circulating parasites and a broad range of symptoms
(same individuals can develop fever, muscle pain, lymphadenopathy or an inflammatory reaction
at the biting site known as chagoma), to a chronic and asymptomatic phase where the parasite load
is nearly undetectable (Devera et al., 2003; Tarleton et al., 2007). Such latent stage could persist
for the lifetime of individuals. However, nearly 30% of chronically infected individuals progress to
a symptomatic disease, with the development of cardiomyopathy, megacolon, or megaesophagus
(Coura and Borges-Pereira, 2010).
The parasite has evolved diverse mechanisms to subvert or escape from the host innate and
adaptative immune system. One of them is the induction of an immunosuppressive state, which
was described both during the acute phase of experimental and human T. cruzi infection (Oladiran
and Belosevic, 2012).This condition is characterized by anergy or clonal deletion of T lymphocytes
as well as polyclonal activation of B cells with production of low affinity antibodies against
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T. cruzi (Ortiz-Ortiz et al., 1980; Maleckar and Kierszenbaum,
1983). Thus, the inhibition of host immunity observed during the
acute phase is an essential way for parasite persistence and the
consequent establishment of chronic disease.
Sialic acids (SAcs) are a family of nine-carbon
monosaccharides present on the surface of all mammalian
cells, conferring diverse biologically activities to glycoproteins
and glycolipids, like the promotion of cell–cell interactions
or masking recognition sites due to its negative charge
(Frasch, 2000). SAcs act as recognition receptors for diverse
pathogens including viruses, bacteria and parasites (Varki, 1997;
Esko and Sharon, 2009). Moreover, pathogenic bacteria
like Escherichia coli K1 and N. meningitidis synthesize
SAcs and use it to decorate their surfaces to evade the
immune system in their mammalian hosts (Vimr and
Lichtensteiger, 2002). Unlike these microorganisms, T. cruzi is
unable to synthesize SAcs de novo. Since T. cruzi requires
SAcs to survive in the mammalian milieu, the parasite
exploites the presence of SAcs on host cells, transferring
the monosaccharide from host sialyl-glycoconjugates to
terminal β-galactoses of acceptor molecules located on its
own surface. This enzymatic activity is carried out by an
unusual parasite enzyme known as trans-sialidase (TS), a
modified sialidase (Previato et al., 1985; Freire-de-Lima et al.,
2015).
TS displays a diversity of biological properties (many of them
independent of their enzymatic activity), which promote the
evasion of the innate and adaptative immune responses, acting
as an important T. cruzi virulence factor (Burleigh and Andrews,
1995). The comprehension of mechanisms involving TS in the
abrogation of immunity against T. cruzi infection is crucial
for the developing and establishment of effective therapeutic
approaches.
Trypanosoma cruzi TRANS-SIALIDASE:
A GLANCE ON ITS CHARACTERIZATION
AND STRUCTURE
The first description of the presence of SAcs residues on
T. cruzi surface came from studies performed in the eighties
(Pereira et al., 1980). Later, it was demonstrated that SAcs
found on the parasite surface were previously transferred from
the extracellular milieu, since no conventional precursors were
found on parasites (Schauer et al., 1983). Furthermore, it was
determined that trypomastigotes also displayed neuraminidase
activity, because they hydrolyzed SAcs residues from erythrocytes
and plasma glycoproteins (Pereira, 1983). Finally, Previato et al.
(1985) demonstrated that T. cruzi performs the enzymatic
transference of SAcs by an alternative route involving a trans-
glycosylation reaction. Subsequent studies demonstrated that
such trans-glycosylase activity is specific for alpha(α)2,3-SAcs
(Schenkman et al., 1991). Further, genetic studies performed to
characterize T. cruzi-TSs genes showed that trans-sialidase and
neuraminidase activities were associated to the same parasite
enzyme (Pereira et al., 1991; Parodi et al., 1992; Uemura et al.,
1992).
Trypanosoma cruzi-TS is part of the TS-superfamily, encoded
by 1430 genes. There have been characterized ∼15 genes for
enzymatically active-TS, and more than 700 for the inactive-TS
which lack the catalytic domain; while the rest are pseudogenes
(Atwood et al., 2005; El-Sayed et al., 2005). Moreover, TS-
superfamily was recently classified by genomic analysis in eight
groups. Active-TS members belong to the group-I, while inactive-
TS members belong to groups-II to VIII (Freitas et al., 2011).
The general TS protein structure derived from metacyclic
and bloodstream trypomastigote forms shows two major regions.
As seen in Figure 1, one region is a N-terminal catalytic
region whereas the other one consist of a C-terminal region
displaying repeats of 12 amino acids in tandem, called SAPA
(by Shed Acute Phase Antigen) (Pollevick et al., 1991). The
hydrophobic catalytic pocket, responsible for the interaction
of transferred SAcs with the terminal β-galactose acceptor,
is a three-dimensional structure rich in aromatic residues
(Buschiazzo et al., 2002). Inactive-TS members belonging to the
TS group II (Freitas et al., 2011) differ from the active ones
in their N-terminal region by the presence of mutations in
catalytic residues causing the lack of enzymatic activity (Tyr342 by
His342 is the commonest mutation) (Figure 1B). These inactive-
TSs are lectin-like proteins since they maintain the capacity of
binding SAcs and β-galactose residues (Cremona et al., 1995,
1999; Oppezzo et al., 2011), and are involved in host cell
attachment and invasion (Freitas et al., 2011). Furthermore,
both TSs are surface glycophosphatidylinositol (GPI)-anchored
molecules, which can be released into the bloodstream by the
action of phosphatidylinositol phospholipase C on GPI-anchors
(Schenkman et al., 1992).
THE Trypanosoma cruzi
TRANS-SIALIDASE IS ABLE TO
OVERCOME THE FIRST LINE OF THE
IMMUNE DEFENSES
As sialic acid residues can be found on the surface of all
mammalian cells, exerting crucial roles in regulating both innate
and adaptative host immunity (Amon et al., 2014), it is not
surprising that T. cruzi takes advantage of such host cell
sialoglycophenotype. In this sense, in addition to transfering SAcs
to the parasite surface, the TS can also transfer SAcs between
host cell glycoconjugates, allowing the parasite to affect the host
immune response (Figure 2).
The subversion of immune response by T. cruzi depends at
first on their early action upon innate compounds. The host
milieu is plenty of potential SAcs donors, allowing the parasite
to acquire a negatively charged cover surface right after entering
into the host, through the reaction catalyzed by TS. The fact
of acquiring such negatively charged mask enables T. cruzi to
circumvent the effects of some serum compounds (Vimr and
Lichtensteiger, 2002). The elimination of this protective cover
by sialidase treatment, make trypomastigotes more susceptible to
the complement-mediated lysis (Kipnis et al., 1981). In addition,
GPI-anchored surface GP160/CRP and T-DAF proteins, putative
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FIGURE 1 | Trans-sialidase structure. (A) Representative scheme of the primary structure of metacyclic- and a bloodstream trypomastigote-TS members
belonging to either Group I (active-TS) or Group II (inactive-TS), showing the N-terminal and C-terminal domains. (B) Representative 3D structure of active (a-TS) and
inactive (i-TS) forms of Trypanosoma cruzi-TS. T. cruzi-TS proteins are bound to the parasite surface through GPI-anchors. Active-TS sialylates parasite’s mucin-like
molecules, as well as host cell surface glycoconjugates. Inactive-TS in turn acts as a parasite adhesin and it is differentiated from a-TS by a single mutation in the
catalytic residue of Tyrosine at the position 342, which is commonly changed by a Histidine.
members of inactive-TS family, conferred protection against
the complement-mediating killing by avoiding C3 convertase
assembly (Tomlinson et al., 1994; Norris, 1998) (Figure 2A).
Furthermore, sialylglycoconjugates present on the parasite
surface due to TS activity, can bind SAcs binding Ig-type
lectins (Siglec-E) on dendritic cells, suppressing the production
of the proinflammatory cytokine IL-12, thus impairing the
central branch connecting the innate and adaptative immune
responses and favoring immunosuppression (Erdmann et al.,
2009) (Figure 2B).
Trypanosoma cruzi can infect any nucleated cell, including
phagocytic cells. To facilitate the adhesion and invasion of
mammalian host cells, T. cruzi parasites use different molecules,
including TS (Barrias et al., 2013). The reduced ability of
T. cruzi to invade SAcs-deficient cells compared to wild type
cells, clearly show that key steps of parasitism, such as the
adhesion and invasion of host cells require the participation
of TS (Ming et al., 1993; Schenkman et al., 1993). Moreover,
both active- and inactive-TS seem to participate in these steps
(Barrias et al., 2013). After cellular binding, T. cruzi invades
non-phagocytic host cells by diverse processes that alternatively
require fusion of lysosomes at the site of entry, participation
of plasma membrane components or fusion with endosome
compartments at the site of invasion (de Souza et al., 2010; Barrias
et al., 2013). Regardless of the mechanisms of infection, the
parasite will be later located in a vesicle called parasitophorous
vacuole (Tardieux et al., 1992; de Souza et al., 2010). The
internal membrane of this organelle is enriched with highly
sialylated LAMP proteins (Albertti et al., 2010).The acidic pH
of the parasitophorous vacuole favors the activity of TS in
transferring SAcs from LAMP proteins to the parasite surface.
The desialyzation process renders the vesicle more prone to
lysis by the action of Tc-Tox (a parasite-derived protein with
membrane pore-forming activity), enabling the parasite to
escape into the cytoplasm (Andrews and Whitlow, 1989; Hall
et al., 1992; Rubin-de-Celis et al., 2006; Albertti et al., 2010)
(Figure 2B).
Trypanosoma cruzi parasites can be also internalized via
phagocytosis by macrophages, a process that triggers an oxidative
burst to kill parasites (Alvarez et al., 2011). However, the parasite
can avoid macrophage-induced cytotoxicity using an antioxidant
complex system to ensure their escape into the cytoplasm in
order to establish a productive infection (Piacenza et al., 2009;
Nagajyothi et al., 2012).
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FIGURE 2 | Main roles of T. cruzi TS on the host immune responses. (A) Upon entry in the host milieu, which is rich in SAcs donors, the parasite surface gets a
negatively charged barrier due to a reaction catalyzed by TS, conferring protection against the complement-mediated killing. (B) TS favors T. cruzi escape from the
parasitophorous vacuole, process in which LAMP and Tc-Tox proteins are also shown to be involved. Moreover, TS is able to interfere with IL-12 secretion by
dendritic cells through the interaction between sialylated molecules on T. cruzi surface and Siglecs on dendritic cell surface. (C) SAPA-antigen induces the
production of non-protective antibodies. Moreover, recent findings have show that TS acts on both mature follicular and marginal zone CD220+CD19+B cells to
induce the expression of IL-17 by a non-canonical signaling pathway. These signaling events promote changes in the glycosylation profile of CD45 that result in their
phosphatase activity and subsequent activation of downstream signals leading to the Il-17 gene expression. (D) TS can also induce the activation of CD4+T cells
in vivo. In addition, TS can also promote changes in the sialylation pattern of activated CD8 +T cells, dampening the protective functions of MHC class I-dependent
lymphocyte killing responses against T. cruzi parasites.
Moreover, TS can also remodel the surface of surrounding
host cells. As mentioned earlier, TS can be shed into the
bloodstream, causing removal of SAcs located on platelet
surface, an event that increases their clearance thus favoring the
occurrence of thrombocytopenia (Tribulatti et al., 2005).
Trypanosoma cruzi TRANS-SIALIDASE
COMPROMISES BOTH B AND T CELL
RESPONSES
During the acute phase, it has been shown the involvement of
TS in the polyclonal B-lymphocyte activation (Gao and Pereira,
2001). Probably, the B cell polyclonal activation may restrict
the niche size required for an optimal development of specific
and protective lymphocytes, by increasing the competition for
activation and survival signals in the lymphoid organs (Freitas
and Rocha, 2000; Montaudouin et al., 2013). Interestingly, the
presence of immunodominant epitopes derived from shed acute
phase antigens (SAPAs) shared by TS, drives the production of
non-inhibitory antibodies against regions close to the catalytic
site of the enzyme (Alvarez et al., 2001) (Figure 2C). These
antibodies are produced in a T cell-independent manner, delaying
the acquisition of inhibitory antibodies (Gao and Pereira, 2001;
Gao et al., 2002). Importantly, these inhibitory antibodies are
mainly neutralizing IgG immunoglobulins directed against the
catalytic site of TS, and their production is strongly correlated
with an IFN-γ enriched milieu (Pereira-Chioccola et al., 1994;
Ribeirão et al., 2000; Risso et al., 2007). It is possible that the
SAPA antigens have evolved to avoid the production of protective
antibodies directed against the N-terminal catalytic region, since
they are absent in the epimastigote forms. Additionally, these
antigens are responsible to increase the half-life of TS shed
into the bloodstream (Ribeirão et al., 1997; Buscaglia et al.,
1999). Furthermore, the trypomastigote surface is rich in terminal
α-galactosylmucins, which are also targeted by lytic antibodies.
Nevertheless, the T. cruzi parasites can avoid the killing induced
by human anti-α-galactosyl antibodies by the highly sialylated
negatively charged surface (Chioccola et al., 2000; Buscaglia et al.,
2006).
Interestingly, recent data demonstrate that during T. cruzi
infection, B220+CD19+B cells can produce IL-17, a cytokine
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involved in the protective response against the parasite
(ToselloBoari et al., 2012; Bermejo et al., 2013; Erdmann et al.,
2013) (Figure 2C). Increased levels of IL-17 in the infection
seems to be driven by active-TS acting on CD45 mucins located
on B220+CD19+B cell surface, in a ROR-γt/AhR-independent
manner (Bermejo et al., 2013). Despite that this type of B cells
could be considered as innate cells, such results point out that B
cells and different CD45 isoforms are also targets of T. cruzi-TS
activity (Freire-de-Lima et al., 2010; Muia et al., 2010).
Differentiation, homeostasis and activation processes of T
cells greatly depend on the sialylation process. Thus, T. cruzi-
TS-mediated modifications of the T cell sialophenotype indeed
influence the host immune response.
During acute phase of T. cruzi infection, T cells become
anergic and undergo clonal deletion. Moreover, T cells exhibit
low IL-2 expression and are more prone to suffer apoptosis
after activation (Nunes et al., 1998; Alcaide and Fresno, 2004).
Interestingly, the induction of CD4+Th1 and CD8+ cytotoxic
T-cell protective responses is partly elicited by TS (Rodrigues
et al., 1999). Both active- and inactive-TS forms engage the CD43
sialomucin in CD4+T cells, favoring their activation (Figure 2D).
Such mechanism is shown to be able to rescue T cells from
activation-induced cell death, intensifying the mitogenic capacity
of these lymphocytes (Todeschini et al., 2002). Furthermore, the
antigen-specific CD8+T cell responses are regulated by a distinct
sialylation process (Moody et al., 2001; Pappu and Shrikant,
2004). During T cell activation, the expression of SAcs on
lymphocyte surface is downregulated, leading to the exposure
of desialylated glycans (Priatel et al., 2000). Such decreased
sialylation process is important to augment the reactivity of
T cells for their cognate peptide in the context of MHC class
I molecules (Kao et al., 2005). In this context, recent studies
showed that TS is able to re-sialylate the surface of CD8+T
lymphocytes, limiting the acquisition of antigen-specific CD8+T
cell responses (Figure 2D). These findings suggest that the re-
sialylation ability of TS over activated T cells is an important
parasite evasion strategy that directly influences the T. cruzi
half-life time inside the host by preventing the immune control
elicited by CD8+T cells (Freire-de-Lima et al., 2010). In fact, a
large number of epitopes recognized by CD8+T cells in both
experimental T. cruzi models and human disease is encoded
by the TS family of genes, although the studies reveal that the
epitope immunodominance of TS members varies according to
the parasite strain (Martin et al., 2006).
ROLE OF Trypanosoma cruzi
TRANS-SIALIDASE IN THE
T. cruzi-DRIVEN THYMIC ATROPHY AND
DEVELOPMENT OF UNCONVENTIONAL
EXTRATHYMIC T CELL SUBSETS IN
CHAGAS DISEASE
The thymus is the primary lymphoid organ where bone
marrow-derived T cell precursors undergo differentiation. As
a result of this process, positively CD4+ and CD8+ selected
thymocytes migrate as mature T cells to T-cell areas of peripheral
lymphoid organs (Savino and Dardenne, 2000). Several infectious
pathologies, including Chagas’ disease, promote disturbances
of the intrathymic compartment (Savino, 2006). During the
acute phase of murine T. cruzi infection is commonly observed
FIGURE 3 | Trypanosoma cruzi TS contributes to the thymic atrophy seen during acute phase of Chagas disease. The thymic atrophy caused by T. cruzi
parasite is a complex phenomenon and involves several host–parasite molecule interactions, including those elicited by TS. TS promotes CD4+CD8+ double
positive (DP) cells apoptosis within the thymic nurse cell complex, contributing to the thymic atrophy process. Moreover, TS also modulates the migratory properties
of thymocytes, and may contribute to the abnormal release of DP thymocytes to the periphery.
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an intense thymic atrophy, mainly caused by the depletion
of immature CD4+CD8+ double-positive (DP) thymocytes.
Such phenomenon involves not only thymocyte death but also
their abnormal proliferation and migration responses (Leite de
Moraes et al., 1991; Roggero et al., 2002; Henriques-Pons et al.,
2004).
Interestingly, changes in the cell surface sialylation caused
by TS seem also to play an important role in T. cruzi-induced
morphological and phenotypic thymic alterations (Figure 3).
When TS is artificially shedding to circulation, the parasite
enzyme is able to induce apoptosis of thymocytes. In addition,
even when TS doses became undetectable, thymic apoptosis
could also be observed (Leguizamón et al., 1999). Moreover,
TS-treated animals displayed enhanced thymocyte apoptosis
within the thymic nurse cell complexes, findings resembling
thymic alterations in infected animals. Additionally, the TS
treatment was able to promote a decrease of thymocyte
proliferative ratios after Concanavalin A stimulation, in a
similar manner to those observed in the experimental models
of T. cruzi infection. The use of TS-neutralizing antibodies
apparently rescued the normal thymocyte proliferation indexes
(Mucci et al., 2002). Importantly, the thymocyte apoptosis
induced by TS depends on androgens, since TS administration
in both female and androgen-depleted mice did not result
in the increase of thymocyte death. Furthermore, lactitol, a
competitive inhibitor of TS that blocks the transference of
sialyl residues by TS, was able to prevent the thymic cell
depletion induced by T. cruzi (Mucci et al., 2005, 2006).
Further studies showed that a rise in the glucocorticoid
levels, as consequence of infective stress, is also involved in
the T. cruzi-driven thymic atrophy (Roggero et al., 2006;
Pérez et al., 2007; Lepletier et al., 2013). Interestingly,
it has been reported that glucocorticoids can change the
expression of sialylated and nonsialylated Lewis (a) epitopes
of adhesion molecules involved in leukocyte migration
processes (Delbrouck et al., 2002). Whether similar results
occur during T. cruzi-driven thymic atrophy it remains to be
determined.
Finally, recently studies from our group revealed that TS
influences the thymocyte differentiation process via activation
of MAPK signaling pathways, increasing thymocyte migratory
activity by inducing actin filament mobilization. Such effects
were also related to the ability of TS to modulate the adhesive
properties of thymocytes to thymic epithelial cells. Moreover, we
found increased frequencies of activated DPT cells in the blood
of chronic chagasic patients with heart disease, in association
to elevated titters of anti-TS antibodies as compared to healthy
individuals (Nardy et al., 2013). These findings suggest a probably
role for TS in the intrathymic maturation disturbances and
subsequent abnormal thymic exit of immature thymocytes seen
in T. cruzi infection.
CONCLUDING REMARKS
A successful establishment of an infection relies on efficient
strategies adopted by the infectious agents to evade early
their detection by the host immune system. Considering that
protozoans are the most ancient members of the animal
kingdom, it is conceivable to think that they evolved sophisticated
mechanisms to ensure their survival as intracellular parasites.
T. cruzi is part a diverse group of unicellular organisms that can
modify host cells to their own benefits (Jackson, 2015). In this
review, we highlighted important aspects of T. cruzi immune
evasion involving TS, a major parasite virulence factor. The
diverse functions displayed by this molecule enable the parasite
to interfere in many crucial host biological processes, including
those responsible for protective immune responses. Despite
several years of research directed toward understanding the role
of T. cruzi-derived TS on the host-parasite interplay, there are
still some points to be uncovered, especially those involving the
distribution of genes encoding TS in different parasite strains.
This question becomes even more important if we consider the
coexistence of different T. cruzi strains in their natural reservoirs
(Noireau et al., 2009). The existence of antigen variation within
the parasite population, may lead the expression of competing
T cell epitopes with different affinities to MHC molecules that
could influence the acquisition of protective adaptive immune
responses. Given the importance of TS for the establishment of
an efficient infection, this molecule has gained potential attention
as a drug target for disease therapies. Thus, efforts to understand
the biology of TS would strengthen the use of TS inhibitors in
therapeutic approaches for treatment of Chagas disease.
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